Citations 143

Clinical Reasoning: A 73-year-old man with sarcoidosis and multifocal ischemic strokes

Neurology | September 19, 2016 | Volume: 87 | Issue: 12 | Pages: No page available

10.1212/wnl.0000000000003128 | PMID 27647587

Progressive solitary sclerosis

Neurology | September 17, 2016 | Volume: 87 | Issue: 16 | Pages: 1713-1719

10.1212/wnl.0000000000003235 | PMID 27638926

The contemporary spectrum of multiple sclerosis misdiagnosis

Neurology | August 31, 2016 | Volume: 87 | Issue: 13 | Pages: 1393-1399

10.1212/wnl.0000000000003152 | PMID 27581217

A new dawn for genetic association studies in multiple sclerosis

Neurology Genetics | August 5, 2016 | Volume: 2 | Issue: 4 | Pages: No page available

10.1212/nxg.0000000000000093 | PMID 27540593

Infliximab is a plausible alternative for neurologic complications of Behçet disease

Neurology Neuroimmunology & Neuroinflammation | July 12, 2016 | Volume: 3 | Issue: 5 | Pages: No page available

10.1212/nxi.0000000000000258 | PMID 27458602

Integrated multidisciplinary clinics should be the gold standard in managing progressive MS – YES

Multiple Sclerosis Journal | May 25, 2016 | Volume: 22 | Issue: 9 | Pages: 1126-1128

10.1177/1352458516650526 | PMID 27225677

The cerebellar channelopathy of multiple sclerosis

Neurology | January 7, 2016 | Volume: 86 | Issue: 5 | Pages: 406-407

10.1212/wnl.0000000000002338 | PMID 26740676

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome

Annals of Neurology | November 25, 2015 | Volume: 79 | Issue: 2 | Pages: 288-294

10.1002/ana.24564 | PMID 26599831

ObjectiveThe aim of this work was to evaluate the preprogressive phase in subjects with radiologically isolated syndrome (RIS) who evolve to primary progressive multiple sclerosis (PPMS).MethodsA multicenter RIS cohort was previously established. Demographic, clinical, and radiological characteristics of subjects with RIS that evolved directly to PPMS were compared to those that developed a relapsing disease course from onset (clinically isolated syndrome [CIS] or relapsing‐remitting MS) and were also compared to two other population‐ and clinic‐based PPMS cohorts.ResultsOf the 453 subjects with RIS, 128 evolved to symptomatic MS during the follow‐up (113 developed a first acute clinical event consistent with CIS/MS, 15 evolved to PPMS). PPMS prevalence (11.7%) and onset age (mean ± standard deviation; 49.1 ± 12.1) in the RIS group were comparable to other PPMS populations (p > 0.05). Median time to PPMS was 3.5 years (range, 1.6–5.4). RIS evolved to PPMS more commonly in men (p = 0.005) and at an older age (p < 0.001) when compared to CIS/MS, independent of follow‐up duration. Subjects who evolved to PPMS had more spinal cord lesions (100%) before symptomatic evolution than those that developed CIS/MS (64%) and those that remained asymptomatic (23%) within the follow‐up period (P = 0.005). Other MRI characteristics in the preprogressive phase of PPMS were indistinguishable from CIS/MS.InterpretationSubjects with RIS evolve to PPMS at the same frequency as expected from general MS populations in an age‐dependent manner. Besides age, unequivocal presence of spinal cord lesions and being male predicted evolution to PPMS. Our findings further suggest that RIS is biologically part of the MS spectrum. Ann Neurol 2016;79:288–294
Naturally Occurring Monoclonal Antibodies and Their Therapeutic Potential for Neurologic Diseases

JAMA Neurology | September 21, 2015 | Volume: 72 | Issue: 11 | Pages: 1346

10.1001/jamaneurol.2015.2188 | PMID 26389734

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis

Neurology | July 25, 2015 | Volume: 85 | Issue: 8 | Pages: 722-729

10.1212/wnl.0000000000001856 | PMID 26208962